Please enable JavaScript
Powered by Benchmark International Archives - Page 969 of 1942 - Matribhumi Samachar English
Wednesday, February 04 2026 | 07:02:33 PM
Home / International (page 969)

International

Pacifica Silver Closes $1.0 Million Private Placement Financing

Vancouver, British Columbia–(Newsfile Corp. – July 25, 2025) – Pacifica Silver Corp. (CSE: PSIL) (“Pacifica Silver Corp” or the “Company”) is pleased to announce that it has closed its previously announced $1,000,000 non-brokered private placement financing by issuing 2,500,000 common shares (“Shares”) at a price of $0.40 per Share (the …

Read More »

Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds

King of Prussia, Pennsylvania–(Newsfile Corp. – July 25, 2025) – Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer, today announced the entry into definitive agreements to exercise certain outstanding warrants to purchase up to an aggregate …

Read More »

Beedie Investments Ltd. Announces Filing of Updated Early Warning Report

Vancouver, British Columbia–(Newsfile Corp. – July 25, 2025) – Beedie Investments Ltd. (“Beedie Capital”) entered into a forbearance and first supplemental credit agreement on July 9, 2025 with the Enthusiast Gaming Holdings Inc. (the “Company”), as borrower, and certain subsidiaries of the Company, as guarantors (the “Beedie Forbearance Agreement”), which …

Read More »

Zephyr Closes Private Placement

Halifax, Nova Scotia–(Newsfile Corp. – July 25, 2025) – Zephyr Minerals Ltd. (TSXV: ZFR) (“Zephyr” or the “Company“) is pleased to announce, further to its news release of June 11, 2025, the Company has closed a non-brokered private placement through the issuance of 6,500,000 units (each a “Unit“) for gross …

Read More »

Phio Pharmaceuticals Announces Pathology Results for Four of Five Patients in Fourth Cohort

Complete Pathologic Response in patient with cutaneous squamous cell carcinoma Partial Response in Stage 4 metastatic Merkel cell patient King of Prussia, Pennsylvania–(Newsfile Corp. – July 25, 2025) – Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to …

Read More »